Julian Moran, BSc
Rationale and design of the PIONEER PLUS study evaluating high dose oral GLP-1 receptor agonist therapy for the treatment of type 2 diabetes
Rationale and design of the PIONEER PLUS study evaluating high dose oral GLP-1 receptor agonist therapy for the treatment of type 2 diabetes
KIM-1-mediated Proximal Tubular Uptake of Palmitic Acid-Albumin Leads to Progressive Diabetic Kidney Disease
Strategies to Promote Equity in the BWH COVID-19 Recovery Center
Computerized clinical decision support: Defining end-user requirements for primary care staff and patients
Sex differences in bronchial mucus plugging among COPD patients
A Guide to Being Mortal: “Testing the What Matters to Me Workbook”
